 |
English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12441/13613 (91%)
Visitors : 2360837
Online Users : 118
|
|
|
Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/13745
|
| Title: | The effect of the APOE-epsilon4 allele on the cholinergic circuitry for subjects with different levels of cognitive impairment |
| Other Titles: | The effect of the APOE-ε4 allele on the cholinergic circuitry for subjects with different levels of cognitive impairment |
| Authors: | Lai, YL;Chen, K;Lee, TW;Tso, CW;Lin, HH;Kuo, LW;Chen, CY;Liu, HS |
| Contributors: | NHRI Graduate Student Program;Institute of Biomedical Engineering and Nanomedicine |
| Abstract: | Background: Cholinergic deficiency has been suggested to associate with the abnormal accumulation of Aβ and tau for patients with Alzheimer's disease (AD). However, no studies have investigated the effect of APOE-ε4 and group differences in modulating the cholinergic basal forebrain-amygdala network for subjects with different levels of cognitive impairment. We evaluated the effect of APOE-ε4 on the cholinergic structural association and the neurocognitive performance for subjects with different levels of cognitive impairment. Methods: We used the structural brain magnetic resonance imaging scans from the Alzheimer's Disease Neuroimaging Initiative dataset. The study included cognitively normal (CN, n = 167) subjects and subjects with significant memory concern (SMC, n = 96), early mild cognitive impairment (EMCI, n = 146), late cognitive impairment (LMCI, n = 138), and AD (n = 121). Subjects were further categorized according to the APOE-ε4 allele carrier status. The main effects of APOE-ε4 and group difference on the brain volumetric measurements were assessed. Regression analyses were conducted to evaluate the associations among cholinergic structural changes, APOE-ε4 status, and cognitive performance. Results: We found that APOE-ε4 carriers in the disease group showed higher brain atrophy than non-carriers in the cholinergic pathway, while there is no difference between carriers and non-carriers in the CN group. APOE-ε4 allele carriers in the disease groups also exhibited a stronger cholinergic structural correlation than non-carriers did, while there is no difference between the carriers and non-carriers in the CN subjects. Disease subjects exhibited a stronger structural correlation in the cholinergic pathway than CN subjects did. Moreover, APOE-ε4 allele carriers in the disease group exhibited a stronger correlation between the volumetric changes and cognitive performance than non-carriers did, while there is no difference between carriers and non-carriers in CN subjects. Disease subjects exhibited a stronger correlation between the volumetric changes and cognitive performance than CN subjects did. Conclusion: Our results confirmed the effect of APOE-ε4 on and group differences in the associations with the cholinergic structural changes that may reflect impaired brain function underlying neurocognitive degeneration in AD. |
| Date: | 2021-10-13 |
| Relation: | Frontiers in Neurology. 2021 Oct 13;12:Article number 651388. |
| Link to: | http://dx.doi.org/10.3389/fneur.2021.651388 |
| JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1664-2295&DestApp=IC2JCR |
| Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:000713631000001 |
| Cited Times(Scopus): | https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85118195151 |
| Appears in Collections: | [其他] 期刊論文
[郭立威] 期刊論文
|
Files in This Item:
| File |
Description |
Size | Format | |
|---|
| PUB34721251.pdf | | 2620Kb | Adobe PDF | 256 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|
